Journal of Nephropathology · 2012 · 37 citations · 13 references
MedicineBiochemistryNephrologyLipid BiochemistryRenal PathophysiologyRenal PharmacotherapyChronic Kidney DiseaseDyslipidemia ManagementDyslipidemia PharmacotherapyRenal DiseaseCardiovascular Disease ManagementCkd ProgressionEnzyme ActivityRenal Antioxidant DefenseRenal Oxidative Stress
Recent studies have focused on decrease activity of paraoxonase (PON) in chronic kidney disease (CKD) patients. Paraoxonase (PON) enzyme is altered in many diseases and is related to lipid abnormalities and antioxidant activities. Patients with CKD often have lipid abnormalities. Lipid abnormalities in CKD patients increase the risk of cardiovascular diseases in CKD patients. In CKD patients, PON activity and its mechanism have developed a new idea for treatment options to reduce the risk of cardiovascular disease. This review article is focused on the role of PON in dyslipidemia in the CKD patients. © 2014 by Journal of Nephropathology (JNP).
13
Decrease of serum paraoxonase activity in chronic renal failure.
Thierry Dantoine, J. Debord, J.P. Charmes et al. · Journal of the American Society of Nephrology · 1998 · 186 citations
Medicine, Biochemistry, Nephrology +10
Alejandro Gugliucci, Nicole Lunceford, Eriko Kinugasa et al. · Clinica Chimica Acta · 2007 · 43 citations
Medicine, Nephrology, Dialysis +9